Variables | Kochujang group (n=30) | Placebo group (n=30) | P-valuea |
---|---|---|---|
Age (y) | 42.1±1.31 | 43.0±2.2 | 0.786 |
Sex (M/F) b | 4/26 | 3/27 | 0.688b |
Weight (kg) | 68.0±1.5 | 570.2±2.3 | 0.431 |
BMI (kg/m2) | 26.7±0.4 | 27.4±0.8 | 0.383 |
WHR | 0.91±0.005 | 0.90±0.006 | 0.242 |
Visceral fat (cm2) | 79.0±5.1 | 78.3±4.4 | 0.926 |
Subcutaneous fat (cm2) | 250.5±23.6 | 249.6±16.0 | 0.977 |
SBP (mmHg) | 118.1±2.43 | 119.4±2.2 | 0.681 |
DBP(mmHg) | 74.4±1.7 | 75.7±1.5 | 0.563 |
Pulse rate(bpm) | 68.7±1.9 | 71.49±1.8 | 0.216 |
FPG(mg/dl) | 83.3±1.6 | 81.6±1.5 | 0.449 |
HbA1c(%) | 5.4±0.1 | 5.4±0.1 | 0.894 |
TC (mg/dL) | 192.4±4.7 | 195.3±6.0 | 0.649 |
TG (mg/dL) | 118.4±10.2 | 122.0±12.1 | 0.703 |
HDL (mg/dL) | 52.0±1.7 | 52.5±2.1 | 0.822 |
LDL (mg/dL) | 123.6±4.4 | 125.12±5.8 | 0.835 |
FFA (μEq/L) | 612.4±40.5 | 549.5±33.9 | 0.239 |
ApoA1 (g/dL) | 1.44±0.03 | 1.45±0.04 | 0.770 |
ApoB (g/dL) | 0.86±0.03 | 0.87±0.04 | 0.944 |